Improving memory support in PTSD therapy
Official title: Enhancing Memory and Learning in Cognitive Processing Therapy for Post Traumatic Stress Disorder (PTSD)
Run by Boston University · NCT05310097 · Data updated 2026-11-12
This study is testing whether adding memory support techniques to therapy can help people with PTSD remember and benefit more from their treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Boston University Academic / other |
| Locations | 1 site (Jamaica Plain, Massachusetts) |
| Status | Recruiting |
| Started | January 4, 2023 |
| Main results expected | January 2027 |
| Study ends | April 2027 |
| Registry record updated | April 1, 2026 |
| Trial ID | NCT05310097 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults diagnosed with PTSD, particularly veterans, who are stable on psychiatric medications.
✕Probably not a fit
Patients with unstable bipolar disorder, psychosis, or significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of combining Memory Support (MS) with Cognitive Processing Therapy (CPT) for individuals diagnosed with PTSD. The aim is to enhance the learning and retention of therapy content by integrating techniques that facilitate memory encoding, consolidation, and retrieval. A pilot randomized controlled trial will compare the outcomes of participants receiving CPT alone versus those receiving CPT with MS. The study will assess both the efficacy of the combined approach and its acceptability among participants.
Why it matters
Potential benefit: If successful, this approach could significantly improve the therapeutic outcomes for patients with PTSD by enhancing their ability to learn and remember critical therapy content.
How similar studies have gone: Previous studies have shown that integrating memory support techniques into cognitive therapies can improve outcomes, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current diagnosis of PTSD as determined by the Clinician Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) * For potential participants on psychiatric medication, dose must be stable for the past four weeks. * Veteran status Exclusion Criteria: * Current DSM-5 diagnoses of unstable bipolar disorder, past or present psychosis, or organic mental disorder * Active suicidal or homicidal ideation with plan or intent * Current moderate or severe substance use disorder, as defined by DSM-5 \[i.e., at least 4 diagnostic symptoms of Substance use disorder (SUD) present\] * Prior receipt of CPT or concurrent therapy for PTSD * Significant cognitive impairment as indicated by a score \<10th percentile on the Montreal Cognitive Assessment * History of moderate or severe traumatic brain injury (TBI) based on the Ohio State University TBI Identification Method and Veterans Administration/ Department of Defense (VA/DOD) guidelines * High verbal memory ability, as indicated by a score \>1 standard deviation (SD) above the population mean on the California Verbal Learning Test® Third Edition (CVLT-3) immediate recall task
Where it's running
-
VA Boston Healthcare System
Jamaica Plain, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Joseph Carpenter, PhD MA — VA Boston Healthcare System, BUSM Psychiatry Dept.
- Study coordinator: Joseph Carpenter, PhD MA
- Email: jcarpen@bu.edu
- Phone: 617-435-5319
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Short-Term Intensive PTSD Treatment for Military Personnel
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.